Waldencast Reports Q2 2024 Financial Results
Provided By GlobeNewswire
Last update: Aug 27, 2024
$63.3 million of Net Revenue Q2 2024
+25.7% net revenue Comparable Growth: +30.9% Obagi Medical and +20.0% Milk Makeup vs Q2 2023
Adjusted EBITDA of $6.3 million, up +64.5% vs Q2 2023
